Faulkner, R. et al. (2004) BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients. Blood, 103(2), pp. 428-434.
Full text not currently available from Enlighten.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | McQuaker, Dr Grant |
| Authors: | Faulkner, R., Craddock, C., Byrne, J., Mahendra, P., Haynes, A., Prentice, H., Potter, M., Pagliuca, A., Ho, A., Devereux, S., McQuaker, G., Mufti, G., Yin, J., and Russell, N. |
| College/School: | College of Medical Veterinary and Life Sciences |
| Journal Name: | Blood |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details